Recently, P. acnes is considered to involve in the pathogenesis of acne by activating the inflammasomes and by inducing IL-1b oversecretion in in vivo and in vitro studies. 7, 8 Genetic factors are considered to be important in acne pathogenesis as family history of severe acne is detected in some patients with severe acne. 9 Polymorphisms of genes encoding important cytokines playing key roles in acne pathogenesis attract attention of researchers. Transition of guanin to adenin in the promoter -308 locus of TNF a results in 6-to 9-fold increase in the transcription of the cytokine. 10 The polymorphic variants of TNF a-308 are suggested to be associated with acne formation in different populations. [11] [12] [13] [14] [15] [16] [17] The increase in C allele amount (C<T) in the -511 locus of IL-1b leads oversecretion of IL-1b cytokine. 18 When searched, we could not find any report about the association of IL-1b polymorphisms with acne. Therefore, in this study, we hypothesized that genotypic variant involving -308 locus of TNF a gene and -511 locus of IL-1b may be associated with acne, acne severity, and scarring acne.
2 | ME TH ODS
| Subjects
The prospective case-control study was conducted in the derma- 
| RESULTS
According to GAGS, patients were subclassified into mild, moderate, and severe acne patients. The subgroups and controls were similar related to age, gender; and all acne severity subgroups were similar related to age, gender, acne duration, and onset age of acne (all P > .05) ( Table 1) .
Upon dermatological examination, scarring acne was detected in 36 patients (30%). Scarring acne group (SA) and NSA group were similar related to age, gender, acne duration, and onset age of acne (all P > .05) ( Table 2 ).
Genotyping of IL-1b-511 and TNF a-308 locuses was performed for all patients and control subjects. Genotype frequencies for all participants are shown in Tables 3 and 4 . The distribution of the GG, GA, and AA genotypes of TNF a-308 and the CC, CT, and TT genotypes of IL-1b-511 was similar between the patients with acne and healthy subjects. These genotypic variants were not found to be associated with acne severity and scarring acne (all P > .05).
As the presence of C allele and A allele is associated with increased expression of IL-1b-511 and TNF a-308, respectively, we re-grouped the related genotypes and compared with acne patients and healthy subjects. CC+CT versus TT and GA+AA versus AA groups were similar between patients and controls, and no protective effect of TT and GG genotypes was shown related to acne, acne severity, and scarring acne (Tables 3 and 4 ).
Investigations about the association of TNF a polymorphisms and acne are limited in number. [11] [12] [13] [14] [15] [16] [17] In our study, we did not find an association of TNF a-308 G>A and IL1 b-511 C<T genetic polymorphisms with acne and acne severity. In another study from Turkey, another study, severity of innate immune response in early inflammation in the epidermis is proposed to have a link with acne scarring. 29 Hypertrophic scars and keloids may emerge in consequence of cutaneous injury as observed in acne. Histopathological examinations of keloid tissues revealed upregulation of many proinflammatory cytokines such as IL-1a, IL-1b, IL-6, and TNF a.
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Early increase in serum decorin and IL-1b levels was detected to be predictive in the development of postburn hypertrophic scars.
IL-1b is suggested to have profibrotic effects, and its interaction with local and systemic factors may lead hypertrophic scarring. T A B L E 3 Frequencies of IL-1b-511 C/T and TNF a-308 G/A genetic variants in acne patients and controls Otherwise, we also suggest that T-cell subsets and regulatory mechanisms of T cells also take attention to be investigated in scarring acne as scarring is suggested to be related to a hypersensitivity reaction. 
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